CDH1 and non-small cell lung carcinoma: First, we observed that the downregulation of TdIF1 following the siTdIF1 treatment of NSCLC cells reduced LSD1 (Figure 5A) and increased H3K4me2 (Figure 5A,B) at the E-cadherin promoter.